CAAS Capital Management’s Boston Scientific BSX Stock Holding History

CAAS Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$37.3K	Buy	+370	New	+$37.3K	﹤0.01%	433
2022 Q1	–	Sell	-6,764	Closed	-$293K	–	688
2021 Q4	$287K	Hold	6,764	–	–	0.01%	625
2021 Q3	$293K	Sell	6,764 -9,000	-57%	-$398K	0.01%	700
2021 Q2	$674K	Sell	15,764 -26,736	-63%	-$1.12M	0.01%	681
2021 Q1	$1.64M	Buy	42,500 +22,700	+115%	+$859K	0.02%	648
2020 Q4	$712K	Buy	+19,800	New	+$714K	0.01%	648

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CAAS Capital Management's BSX Position: Q1 2025 in Review

CAAS Capital Management opened a new position in Boston Scientific (BSX) in Q1 2025: 370 shares worth $37.3K. The stake represents ﹤0.01% of the portfolio and ranks #433 among its holdings. This is a return to the name: CAAS Capital Management previously reported a position in BSX as recently as Q4 2021.

CAAS Capital Management first reported a position in BSX in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.64M in Q1 2021. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

CAAS Capital Management held 370 shares of Boston Scientific worth $37.3K as of Q1 2025.
Boston Scientific was a new CAAS Capital Management position in Q1 2025.
Boston Scientific made up ﹤0.01% of CAAS Capital Management's portfolio in Q1 2025, its #433 holding.
CAAS Capital Management first reported a position in Boston Scientific in Q4 2020 and has held it in 6 quarters since.
CAAS Capital Management's Boston Scientific position peaked at $1.64M in Q1 2021.
1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on CAAS Capital Management's 13F filing for Q1 2025, filed 1 May 2025.